Бухоро вилоятида яшовчи ва постменопауза давридаги 50 ёшдан 80 ёшгача бўлган 378 нафар аёлда сўров ўтказилди. Бухоро вилоятидаги текширилган аёллар орасида постменопаузал остеопороз тарқалганлиги 24,1%ни, остеопения 33,6%ни ташкил қилди. Ёш ошган сари суяк тўқимасининг минерал зичлиги (СТМЗ) меъёрда бўлган аёллар сони камайиб борди (50-59 ёшдаги 50,5%дан ≥70 ёш бўлганларда 5,0%гача). Аёлларнинг ярмидан камроғи сут махсулотларини доимий қабул қилган (43,7%) ва ҳар куни камида 30 минут жисмоний фаол бўлган (46,3%). Эрта менопауза суяк тўқимасининг минерал зичлиги меъёрда бўлган аёлларга нисбатан (20,6%), остеопорозли аёлларда кўпрок учради (39,6%). Текширилган аёллар орасида сут махсулотларини доимий истеъмол қилмаслик, паст жисмоний фаоллик ва менопауза давомийлиги остеопорознинг хавф омиллари эканлиги аниқланди.
Questioning for 378 women from 50 to 80 years of age who are in menopause and live in Bukhara region. The prevalence of osteoporosis among surveyed postmenopausal women living in Bukhara region comprised 24.1%, osteopenia - 33.6%.With increase of age there the number of women with normal BMD significantly declines (from 50.5% at age of 50-59 to 5,0% - at ≥70).Dairy products were regularly consumed by less than half of the women (43.7%) and 46.3% were physically active during at least 30 minutes daily. Early menopause was significantly more common among women with osteoporosis (39.6%), than in women with nBMD (20.6%). Irregular consumption of dairy products, low physical activity and the duration of menopause were the risk factors in the studied group of women.
| № | Muallifning F.I.Sh. | Lavozimi | Tashkilot nomi |
|---|---|---|---|
| 1 | Ismailov S.I. |
| № | Havola nomi |
|---|---|
| 1 | 1. - 2. - 2004. - -22. 3. - - 4. Распространенность постменопаузального остеопороза в Бухарской области 46 Проблемы биологии и медицины, 2016, №4 (91) 2012. - -28. 5. 2014. - http://www.lvrach.ru 6. - 2005. - -44. 7. 53. 8. 9. - 0. - 10. 1997. - 15. http://www.rmj.ru/ 11. 2009. - - http://www.lvrach.ru/ 12. 2010. - -30. 13. - 2011. - - -98. 14. Alswat K., Adler S. Gender differences in osteoporosis screening: retrospective analysis//Arch Osteoporos. 2012. Vol.7. P.311-313. 15. Bonaiuti D., Arioli G., Diana G. Rehabilitation treatment Guidelines in postmenopausal and senile Osteoporosis//Eura Medicophys. 2005. Vol.41. P.315337. 16. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis//Am. J. Med. 1993. Vol.94. P.646-650. 17. Desai S., Gravallese E., Shadick N. et al. Hand bone mineral density is associated with both total hip and lumbar spine bone mineral density in post menopausal women with RA//Rheumatology (Oxford). - 2010. - Vol.49(3). - P.513519. 18. Hippisley-Cox J., Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of Q Fracture Scores//BMJ. 2009. Vol.339. P.b4229. 19. Ismailov S.I., Abboskhodjaeva L.S., Alikhanova N.M. Epidemiology of postmenopausal osteoporosis and related risk factors in female residents of Tashkent and Namangan (Republic of Uzbekistan)//International Journal of Biomedicine. 2015. Vol.5(2). P.95-99. 20. Ismailov S.I., Abboskhuzhaeva L.S., Alikhanova N.M., Allayarova G.I. The structure and prevalence of major risk factors of osteoporosis in Uzbek women over 50//International Journal of Clinical Medicine. 2016. Vol.7. P.712-721. 21. SCOPE: a scorecard for osteoporosis in Europe//Arch Osteoporosis. 2013. - Vol.18. P.144. 22. Miller P. Denosumab: anti-RANKL antibody //Curr Osteoporos Rep. - 2009. Vol.7(1). P.18-22. 23. Unni S., Yao Y., Milne N. et al. An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database// Osteoporos Int. 2015. Vol.26(2). - P581-587. |